Fresenius SE is a leading global healthcare group dedicated to providing life-saving therapies and high-quality care. The company operates across several key healthcare sectors, including dialysis services, hospital care, and the production of essential medicines and medical technologies.
Core Business Segments:
- Fresenius Medical Care: A world leader in dialysis products and services.
- Fresenius Kabi: Specializes in essential medicines, infusion therapies, and clinical nutrition for critically and chronically ill patients.
- Fresenius Helios: Operates one of Europe’s largest private hospital networks, including Helios Kliniken in Germany and Quirónsalud in Spain.
- VAMED: Manages healthcare projects and facilities.
Strategic Focus & Innovation: Through its #FutureFresenius strategy, the company focuses on innovation, operational excellence, and expanding access to healthcare. Key initiatives include advancing biosimilars (e.g., denosumab biosimilars), developing scalable cell therapy manufacturing through partnerships (e.g., with TQ Therapeutics), and leveraging AI to optimize biomanufacturing processes (e.g., collaboration with HP Inc. via mAbxience).
Global Presence & Impact: Fresenius is deeply rooted in markets worldwide, with significant operations in Europe and the Americas. The company is committed to strengthening local supply chains, as evidenced by its partnership with Phlow Corp. to secure U.S. production of essential epinephrine, and to creating sustainable value for all stakeholders.
数据统计
相关导航
